Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

Innovative drug delivery system a breath of fresh air

20-Jun-2007 - The little sister of the respirator protecting against viruses and air pollution has blown in, and its makers are plugging the innovation as a "breakthrough" in pulmonary drug delivery.

Two pharma latest to catch pandemic preparedness bug

19-Jun-2007 - The US Government is not sneezing at the potential for an influenza pandemic and has awarded two new vaccine manufacturing contracts to keep the sniffles at bay.

CORVUS throws blood brain barrier a curve ball

19-Jun-2007 - Researchers have developed a new way to deliver drugs into the brains of mice, which could herald a new dawn for the sufferers of brain diseases such as Alzheimer's.

Cosmo gets to the bottom of IBD

19-Jun-2007 - Cosmo Pharmaceuticals is cementing its place in the inflammatory bowel disease (IBD) drug market with eight new drugs in various stages of reformulation using the company's cutting-edge MMX technology, the company announced recently.

Respirics to sell-off MD Turbo technology

14-Jun-2007 - US pulmonary drug delivery specialist Respirics has decided to sell its assets relating to its MD Turbo product to focus on its Acu-Breathe powder inhaler platform.

KV boosts drug delivery abilities

14-Jun-2007 - KV Pharmaceutical has snapped up a specialist coatings firm that it hopes will enhance the company's drug delivery product pipeline.

Injectable asthma formulation uses Captisol technology

13-Jun-2007 - Critical Therapeutics is developing a new injectable formulation for the treatment of asthma, and is the latest company to use Captisol technology to achieve it.

Kurve Technology and Schering-Plough expand agreement

12-Jun-2007 - Schering-Plough and Kurve Technology have signed a new agreement involving Kurve's nasal drug delivery device, which follows on the heals of a partnership formed between the two companies last year.

Intranasal NSAID a first for pain relief

07-Jun-2007 - The first ever non-steroidal anti-inflammatory drug (NSAID) to be delivered via the nose has been developed, and its makers are heralding it as "an important breakthrough in treating pain".

Anticancer nanodelivery vehicles

07-Jun-2007 - Researchers from UCLA in the US, have created a new nanoparticle delivery system to allow water-insoluble drugs to be released into cancer cells.

Active Biotech drug could have the edge in oral MS race

07-Jun-2007 - A joint effort to develop a winning oral formulation for the treatment of multiple sclerosis (MS) has taken another step towards the finish line with initiation of Phase III trials for the novel laquinimod compound.

Million Euro milestone for GSK drug

06-Jun-2007 - An Italian firm specialising in novel drug delivery technologies is due to receive a lump sum of €1m following the successful development of a new formulation of a GlaxoSmithKline (GSK) drug.

Bio-film uses fuel and dairy byproducts

05-Jun-2007 - A new method to create biodegradable protective films from dairy and biofuel byproducts has been developed, US scientists announced today.

Cobra gets DTI grant for oral bid flu, AIDS vaccines

04-Jun-2007 - The UK Department of Trade and Industry (DTI) has awarded £1.1m (€1.62m) to a consortium led by Cobra Biomanufacturing for a project applying the company's ORT-VAC technology to the development of oral vaccines for avian influenza and HIV/AIDS.

Capsulution and Qiagen combine nanotechnology, oligonucleotides

04-Jun-2007 - Germany's Capsulution Nanoscience is tapping into Qiagen's molecular diagnostics expertise in a collaboration that will explore new diagnostic and therapeutic possibilities for cancer and other diseases.

Softgel formulation to challenge Abbott drug

31-May-2007 - Two firms have announced a licence and supply agreement for a novel formulation of valproic acid presented as a softgel capsule, which could challenge Abbott's top selling drug Depakote (divalproex sodium).

Alcohol dependence drug shows financial promise

30-May-2007 - Sales of Alkermes's new drug for alcohol dependence are on a high following its release in June last year, and have contributed a hefty portion to the company's coffers.

Drug delivery in liposomes could be thing of the past

30-May-2007 - The use of liposomes as a drug delivery system could be old news if a new and improved lipid-like nanoparticle lives up to its potential, according to a team of Austrian and American scientists.

Iomai changes tack with flu vaccine patch

29-May-2007 - Iomai Corporation is scoping out new antigen possibilities after its patch-based vaccine for seasonal influenza failed to match the immune response of the same vaccine administered by injection in a Phase I clinical trial.

FluMist problems drag on

29-May-2007 - Despite promising opinions regarding the extension of the age indication for MedImmune's inhalable flu vaccine FluMist, the US Food and Drug Administration (FDA) is withholding any final decisions until manufacturing violations have been rectified.

Oral calcitonin into Phase III for osteoarthritis

29-May-2007 - An oral formulation of salmon calcitonin based on Emisphere Technologies' eligen delivery system has entered Phase III clinical trials for the treatment of osteoarthritis.

Inovio's electroporation tech delivers the goods in trial

24-May-2007 - Inovio Biomedical, a US company developing novel DNA immunotherapies and other treatments based on electroporation technology, has reported interim data from a Phase I/II clinical study showing that its MedPulser system significantly enhanced the potency of an experimental prostate cancer vaccine.

Inhaler solution to premature ejaculation hasn't come too soon

24-May-2007 - The end of premature ejaculation is in sight as a simple inhalation of a drug promises to prolong the action under the sheets.

ACCU-BREAK aims to divide and rule with tabletting tech

23-May-2007 - Novel tabletting technology developed by US company ACCU-BREAK Pharmaceuticals promises to solve the problem of uneven doses when pills are split by hand.

New insulin product takes the nasal route

23-May-2007 - A young start-up company is gearing up to challenge the likes of Pfizer by developing a new insulin product, based on its novel nano-based intranasal delivery technology.

Sign up for your free newsletter